Replication Data for: Direct oral anticoagulant and antiplatelet combination therapy: Hemorrhagic events in coronary artery stent recipients

Using a 40% random sample of the Medicare beneficiaries
enrolled in fee-for-service Medicare Parts A (inpatient), B (outpatient)
and D (prescription) coverage, residing in the U.S., we identified
a cohort of patients receiving inpatient coronary artery stents
in 2010–2012 (Table S1). The year 2010 was selected as the baseline
year because DOACs appeared on the market in 2010. Each
patient’s first stent episode between 2010 and 2012 served as
the index stent episode. Patients dying within 30 days of the index
stent episode were excluded. Patients not enrolled Medicare Part D
or not using prescription benefits (i.e. no prescription fill record) in
the 120 days preceding index stent were also excluded. We also
excluded cancer patients because of their potentially complicated
anticoagulation profile.